The return to work was filled with emotion for Carlo Vanzini, the historic voice of Formula 1 in Italy. After difficult ...
A new tool co-developed by investigators from Cedars-Sinai Health Sciences University can predict which of two available chemotherapy options for pancreatic cancer would be more effective for an ...
Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...
A Mayo Clinic study is providing new insights into how treatment sequence can affect survival in patients with early-stage pancreatic cancer, suggesting that many patients may benefit from receiving ...
BEIJING, March 9, 2026 /PRNewswire/ -- Earlier this year, The New York Times published an article titled "In China, A.I. Finds Pancreatic Cancer That Doctors May Miss," detailing the medical journey ...
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. The test combines four ...
Pancreatic cancer remains one of the deadliest cancers, with few effective treatment options and limited benefit from immunotherapy, which has transformed care for many other cancer types. In diseases ...
For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer.
“Large-scale efforts need to be made" in the fight against these cancers, said paper author Dr. Ju Dong Yang.
Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial ...
Cedars Sinai tool predicts the best chemotherapy regimen for advanced pancreatic cancer using AI analysis of biopsy images.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results